Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6123218 | Journal of Infection | 2015 | 31 Pages |
Abstract
IP-10 distinguished with high accuracy active TB from LTBI irrespective of HIV infection and declined during anti-TB chemotherapy. Plasma IP-10 may serve as a diagnostic biomarker to differentiate between the stages of TB infection and for monitoring therapy efficacy.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
I. Wergeland, N. Pullar, J. Assmus, T. Ueland, K. Tonby, S. Feruglio, D. Kvale, J.K. Damås, P. Aukrust, T.E. Mollnes, A.M. Dyrhol-Riise,